Skip to content
About Us
About Charnwood Discovery
Partnering With Us
Testimonials
Our Team
News, Events & Resources
News
Blog
Events
Publications & Resources
Case Studies
Resources
Contact Us
Search
Home
Drug Discovery Solutions
Integrated Drug Discovery
Target Validation
Assay Development
Hit Identification
Hit to Lead
Lead Optimization
Direct-to-Biology (D2B)
Bioscience
Assay Development
Biophysical Assays
Cell Based Assays
Biochemical Assay Development
Technologies
ADME / DMPK
In Vitro ADME / DMPK Screening
Pharmacokinetics & Bioanalysis
Metabolite Identification (Met ID)
Computer-aided Drug Design
Target Evaluation
Virtual Screening
Structure-based Drug Design
Ligand-based Drug Design
Discovery Chemistry
Synthetic Chemistry
Medicinal Chemistry
Peptide Synthesis Services
Analytical & Purification
Chemical Development Services
Process Development
Impurity Synthesis
Chemical Manufacturing
Crystallization and Purification
Reaction Screening
Analytical Method Development
Discover our drug discovery solutions.
For more information contact us on
+44 (0) 1298 816700
cls-info@conceptlifesciences.com
Target Approaches
Kinases
GPCRs
Ion Channels
Protein-Protein Interactions
TPD
Therapeutic Areas
Oncology
Inflammation & Immunology
Central Nervous System
Metabolic Diseases
Respiratory Diseases
Infectious Diseases
Rare/Orphan Diseases
About Us
About Charnwood Discovery
Our Team
Partnering With Us
Testimonials
News, Events & Resources
News
Blog
Events
Resources
Case Studies
Careers
Contact Us
September 18, 2023
You are here:
Home
2023
September
18
PROTAC assays & successfully measuring protein degradation
Blog
read more
How to Build Successful Bioassays for Early Drug Discovery
Blog
read more
Future Trends in Bioassay & Drug Screening Technologies
Blog
read more
Categories
Blog
(12)
Events
(23)
News
(6)
Share this post:
LinkedIn
WhatsApp
Clear
Search
Cookie Consent Banner by Real Cookie Banner